Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 5
Results: 15
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 611, doi. 10.1007/s00262-007-0399-8
- By:
- Publication type:
- Article
Acknowledgement.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 753, doi. 10.1007/s00262-008-0472-y
- Publication type:
- Article
Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 677, doi. 10.1007/s00262-007-0406-0
- By:
- Publication type:
- Article
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 719, doi. 10.1007/s00262-007-0411-3
- By:
- Publication type:
- Article
Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 701, doi. 10.1007/s00262-007-0410-4
- By:
- Publication type:
- Article
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 663, doi. 10.1007/s00262-007-0405-1
- By:
- Publication type:
- Article
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 731, doi. 10.1007/s00262-007-0412-2
- By:
- Publication type:
- Article
MYCN as a target for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 693, doi. 10.1007/s00262-007-0409-x
- By:
- Publication type:
- Article
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 647, doi. 10.1007/s00262-007-0402-4
- By:
- Publication type:
- Article
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 745, doi. 10.1007/s00262-007-0436-7
- By:
- Publication type:
- Article
Clinical impact of HLA class I expression in rectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 601, doi. 10.1007/s00262-007-0396-y
- By:
- Publication type:
- Article
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 655, doi. 10.1007/s00262-007-0404-2
- By:
- Publication type:
- Article
Adoptive transfer of T<sub>reg</sub> depleted autologous T cells in advanced renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 623, doi. 10.1007/s00262-007-0400-6
- By:
- Publication type:
- Article
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 685, doi. 10.1007/s00262-007-0407-z
- By:
- Publication type:
- Article
Migration deficit in monocyte-macrophages in human ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 5, p. 635, doi. 10.1007/s00262-007-0401-5
- By:
- Publication type:
- Article